FDA Inspection
Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) – FDA Inspection, Apr 17, 2018
Record Details
This FDA Inspection record concerns Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site), with an inspection on April 17, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 17, 2018
- Product Type
- Drugs
- People
- Kumar G. Janoria (Issuing Officer)
- Laurimer Kuilan-Torres (Issuing Officer)
View Company Profile
ID · 0c4030f5-64da-4dcd-8d4b-cf94c6774baa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1052408
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2026 | Not classified | Office of Inspections and Investigations | |
| January 14, 2025 | Not classified | Office of Inspections and Investigations | |
| July 29, 2024 | Not classified | Office of Inspections and Investigations | |
| September 27, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
- FDA Inspection 1325080 - 2026-06-12
- FDA Inspection 1259422 - 2025-01-14
- FDA Inspection 1250164 - 2024-07-29
- FDA Inspection 1108992 - 2019-09-27
- FDA Inspection 1028446 - 2017-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.